Order Article Reprints

Kuo C-HS, Chiu T-H, Tung P-H, Huang C-H, Ju J-S, Huang AC-C, Wang C-C, Ko H-W, Hsu P-C, Fang Y-F, et al. Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation. Cancers. 2022; 14(2):316. https://doi.org/10.3390/cancers14020316

Kuo, Chih-Hsi Scott, Tzu-Hsuan Chiu, Pi-Hung Tung, Chi-Hsien Huang, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Chin-Chou Wang, Ho-Wen Ko, Ping-Chih Hsu, Yueh-Fu Fang, and et al. 2022. "Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation" Cancers 14, no. 2: 316. https://doi.org/10.3390/cancers14020316

Kuo, C.-H. S., Chiu, T.-H., Tung, P.-H., Huang, C.-H., Ju, J.-S., Huang, A. C.-C., Wang, C.-C., Ko, H.-W., Hsu, P.-C., Fang, Y.-F., Guo, Y.-K., & Yang, C.-T. (2022). Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation. Cancers, 14(2), 316. https://doi.org/10.3390/cancers14020316